Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC

Ipsen SA

05/11/2026 16:33

Nov 5 (Reuters) - Ipsen SA IPN.PA:
LATE-BREAKING DATA RAISES AMBITIONS IN PBC WITH MORE THAN 85% OF PATIENTS ON TREATMENT ACHIEVING ALP NORMALIZATION
AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED WITH 23.3% RECEIVING PLACEBO
Source text: ID:nGNEbYWz6X
Further company coverage: IPN.PA

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))